Thomas G. Ricks - Dec 9, 2021 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Director
Signature
/s/ Mark Ballantyne (Attorney-in-Fact)
Stock symbol
SNSE
Transactions as of
Dec 9, 2021
Transactions value $
$249,600
Form type
4
Date filed
12/13/2021, 03:15 PM
Next filing
Mar 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Purchase $132K +20K +6.63% $6.62 322K Dec 9, 2021 See footnote F1, F3
transaction SNSE Common Stock Purchase $117K +20K +6.22% $5.86 342K Dec 10, 2021 See footnote F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.515 to $6.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set herein.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.755 to $5.9953, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set herein.
F3 These shares are held by the Ricks Family Trust. Thomas Ricks is a trustee of the Ricks Family Trust and accordingly may be deemed to have voting and dispositive power with respect to the shares held by Ricks Family Trust.